Vanda Pharmaceuticals
VNDA
#8787
Rank
HK$1.81 B
Marketcap
HK$29.95
Share price
6.41%
Change (1 day)
-12.87%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2023 (TTM): HK$2.11

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$36.30. In 2022 the company made an earnings per share (EPS) of HK$0.94 a decrease over its 2021 EPS that were of HK$4.70.

EPS history for Vanda Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$2.11124.76%
2022HK$0.94-80%
2021HK$4.7039.53%
2020HK$3.37-80.18%
2019HK$17.01334%
2018HK$3.92-247.06%
2017-HK$2.67-19.05%
2016-HK$3.29-55.32%
2015-HK$7.37-347.37%
2014HK$2.98-156.72%
2013-HK$5.25-31.63%
2012-HK$7.68172.22%
2011-HK$2.82-238.46%
2010HK$2.04-119.7%
2009-HK$10.35-31.61%
2008-HK$15.13-31.32%
2007-HK$22.03-99.27%
2006-HK$3,03836045.14%
2005-HK$8.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.41-244.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.16-213.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-116.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.00-766.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.78-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.44-197.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-HK$34.42-5.18%๐Ÿ‡บ๐Ÿ‡ธ USA